Outbreak spotlights safety of custom-mixed drugs

October 4, 2012 by Marilynn Marchione

Custom-mixed medicines like the steroid shots suspected in a meningitis outbreak have long been a source of concern, and their use is far wider than many people realize.

These medicines are made in private and hospital pharmacies and used to treat everything from cancer to menopause symptoms to .

Often these products are name-brand medicines split into smaller doses, or mixed from ingredients sold in bulk. That can easily lead to contamination if aren't maintained. The germ suspected in the current outbreak can spread in the air.

A shortage of many drugs has forced doctors to stretch supplies and seek custom-made alternatives if the first-choice treatment was not available.

The meningitis outbreak has killed four and sickened at least two dozen in five states.

Explore further: Rare US fungal meningitis outbreak grows; 5 dead (Update)

shares

Related Stories

Rare US fungal meningitis outbreak grows; 5 dead (Update)

October 3, 2012
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.

10 people die of suspected Ebola in Congo

August 22, 2012
(AP) — The World Health Organization says an outbreak of suspected Ebola in eastern Congo has infected at least 15 people, 10 of whom died.

Rare US fungal meningitis outbreak grows; 5 dead (Update)

October 4, 2012
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.

Sierra Leone says cholera killed 66 since January

July 21, 2012
(AP) — Sierra Leone's health ministry says a cholera outbreak has sickened more than 3,800 and killed 66 people since January.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.